FDA Adverse Event Other Summary report: N

KRYPTONITE BONE CEMENT

MDR report key: 1631498 · Received March 12, 2010

Report

Report Number
1226001-2010-00001
Event Type
Other
Date Received
March 12, 2010
Date of Event
September 24, 2009
Report Date
February 12, 2010
Manufacturer
DOCTOR'S RESEARCH GROUP, INC.
Product Code
GXP
PMA / PMN Number
K091382
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

IT IS NOT CLEAR WHAT MAY HAVE CONTRIBUTED TO THIS EVENT. THERE ARE SEVERAL FACTORS THAT MAY HAVE PLAYED A ROLE IN CREATING AN INFECTION, INCLUDING BUT NOT LIMITED TO; SURGICAL PROCEDURE, IMPROPERLY STERILIZED SURGICAL INSTRUMENTATION, PERSONNEL, OR DEVICE. ADDITIONALLY, KRYPTONITE IS CONTRAINDICATED FOR "USE IN A CURRENTLY INFECTED FIELD OR SURGICAL SITE LOCATED NEAR AN INFECTION" AND "USE IN PTS WITH THE FOLLOWING: A RECENT UNTREATED INFECTION". NO DOCUMENTATION WITHIN THE DHR WAS FOUND THAT WOULD INDICATE A NONCONFORMANCE TO SPECIFICATIONS THAT COULD HAVE CONTRIBUTED TO THIS EVENT. IF ADDITIONAL INFO BECOMES AVAILABLE, IT WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

A PT UNDERWENT A CARDIAC PROCEDURE WITH A STERNAL CLOSURE. APPROXIMATELY EIGHT (8) MONTHS POST-OP, A SECOND STERNAL CLOSURE WAS REQUIRED DUE TO A PSEUDOARTHROSIS (NON-UNION). KRYPTONITE MATERIAL WAS NOT UTILIZED IN THE ORIGINAL PROCEDURE. IT WAS REPORTED THROUGH THE DISTRIBUTOR THAT A SOFT TISSUE INFECTION DEVELOPED A FEW DAYS POST-OP AFTER THE REVISION STERNAL CLOSURE, WHICH WAS TREATED WITH VAC. NO REVISION SURGERY WAS REQUIRED. THERE WERE NO NOTED ISSUES WITH THE KRYPTONITE MATERIAL. THE IDENTIFIED PRODUCT AND PRODUCT CODE IS DESIGNATED FOR EXPORT ONLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 KRYPTONITE BONE CEMENT BONE CEMENT GXP DOCTOR'S RESEARCH GROUP, INC. KRYP-Z-03 04232009

Patients

Seq Age Sex Outcome Treatment
1 UNK